SIK inhibition representsa promising novel approach for the treatmentof inflammatory diseases, specifically for those that are characterizedby an imbalance of the immune system such as inflammatory bowel disease(IBD), where a dysregulation of pro- and anti-inflammatory pathwaysin intestinal tissues defines the disease pathogenesis.7 The gene discussed is SIK1; the disease is inflammatory bowel disease.